Overview
Anastasios Konstas practices in Thessaloniki, Greece. Konstas is rated as a Distinguished expert by MediFind in the treatment of Glaucoma. Their top areas of expertise are Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Glaucoma, Vitrectomy, and Trabeculectomy.
Their clinical research consists of co-authoring 116 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 86 articles in the study of Glaucoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GlaucomaKonstas isDistinguished. Learn about Glaucoma.
- Ocular Hypertension (OHT)Konstas isDistinguished. Learn about Ocular Hypertension (OHT).
- Pigment-Dispersion SyndromeKonstas isDistinguished. Learn about Pigment-Dispersion Syndrome.
- Advanced
- Retinopathy Pigmentary Mental Retardation
- TrabeculectomyKonstas isAdvanced. Learn about Trabeculectomy.
- VitrectomyKonstas isAdvanced. Learn about Vitrectomy.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- CataractKonstas isExperienced. Learn about Cataract.
- Corneal TransplantKonstas isExperienced. Learn about Corneal Transplant.
- HypertensionKonstas isExperienced. Learn about Hypertension.
- Interstitial KeratitisKonstas isExperienced. Learn about Interstitial Keratitis.
- Late-Onset Retinal DegenerationKonstas isExperienced. Learn about Late-Onset Retinal Degeneration.